Lv4
616 积分 2023-07-27 加入
Antiviral therapy response in patients with chronic hepatitis B and fatty liver: A systematic review and meta‐analysis
9小时前
待确认
Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial
17小时前
已完结
Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m2 but without diabetes: A phase 2 randomized controlled trial
1天前
已完结
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial
1天前
已完结
Semaglutide ameliorates osteoarthritis progression through a weight loss-independent metabolic restoration mechanism
1天前
已完结
World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
1天前
已完结
The hepatitis B virus promotes the progression of non-alcoholic fatty liver disease through incomplete autophagy
8天前
已完结
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion
8天前
已完结
Increased HBsAg loss in HBeAg-negative patients with chronic hepatitis B and concurrent MASLD
8天前
已关闭
The outcomes and mechanisms of chronic hepatitis B complicated by metabolic dysfunction-associated steatotic liver disease
8天前
已完结
皖公网安备34019202002308
